Logo

Biodesix

Biodesix, Datavant Join in Lung Cancer Data Partnership

Datavant will anonymize lung cancer records from the Biodesix biobank and add real-world data to aid researchers and biopharma companies.

Biodesix Q1 Revenues Soar on COVID-19 Testing

For the three months ended March 31, the firm reported revenues of $28.9 million, compared to $5.1 million in the same period a year ago.

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market
Premium

The firm will commercialize its Primary Immune Response assay as a laboratory-developed test to help guide immunotherapy decisions in lung cancer patients.

Biodesix Secures $30M Term Loan

The firm used the proceeds to repay outstanding borrowings of $25.9 million under its existing loan with Innovatus Life Sciences Lending Fund. 

Biodesix Q4 Revenues More Than Triple on COVID-19 Testing

For the three months ended Dec. 31, the Boulder, Colorado-based firm reported revenues of $27.0 million compared to $8.3 million in 2019.

Jan 8, 2021

Biodesix Preliminary Q4 Revenues Up Over 200 Percent

Dec 11, 2020

Biodesix Q3 Revenues Rise Sharply

Nov 23, 2020

Three Investment Banks Initiate Coverage of Biodesix

Oct 28, 2020

Biodesix Prices $72M IPO

Oct 1, 2020

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Aug 17, 2020

Biodesix Turns to Digital PCR to Maintain Round-The-Clock COVID Testing
Premium

Mar 20, 2020

Biodesix, Bio-Rad Partner on Coronavirus Test

Jan 29, 2020

Biodesix, Streck Partner on Cancer CDx Sample Collection

Nov 8, 2019

People in the News: Roland Diggelmann, Victor Esch, Scott Hutton, David Brunel, More

Jul 29, 2019

Biodesix, Immodulon Collaborating on Pancreatic Cancer Biomarkers

Jul 9, 2019

Biodesix to Develop Blood-Based Lung Cancer Diagnostic Using Thermo Sequencing Panel

Jan 28, 2019

Biodesix, MRM Proteomics Partner on Lung Cancer Assays

Jul 10, 2018

Biodesix Buy Provides Commercial Path Forward for Indi XL2 Lung Nodule Test
Premium

Jul 9, 2018

Biodesix Acquires Integrated Diagnostics

Mar 5, 2018

Biodesix Inks $23M Debt Refinancing

Jan 31, 2018

Biodesix, University of Colorado Partner on Lung Cancer Assay

Dec 14, 2017

Biodesix Putting Focus on Veristrat's Prognostic Capabilities
Premium

Nov 17, 2017

Biodesix Pushes Back Immunotherapy Test Development Timeline
Premium

Jun 20, 2017

Biodesix Receives NY State Approval for GeneStrat Test

Jun 12, 2017

Biodesix, Positive Bioscience Ink Distribution Deal for India

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.